Sabyasachi Sen
Washington DC VA Medical Center · Washington VA Medical Center · GWU
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sabyasachi Sen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:51 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07155694 · Role of Finerenone in African American Veterans With Diabetic Kidney DiseaseWashington D.C. Veterans Affairs Medical Center · not yet recruiting · Diabetic Kidney Disease · principal investigator
- Ph4NCT06110130 · Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKDWashington D.C. Veterans Affairs Medical Center · recruiting · Chronic Kidney Diseases · principal investigator
- Ph4NCT03660683 · Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes MellitusSabyasachi Sen · terminated · Diabetes Mellitus, Type 2, Cardiovascular Diseases · principal investigator
- Ph4NCT02964585 · Role of Canagliflozin on CD34+ Cells in Patients With Type 2 DiabetesGeorge Washington University · completed · Type 2 Diabetes Mellitus · principal investigator
- Ph4NCT02467478 · Linagliptin's Effect on CD34+ Stem CellsGeorge Washington University · completed · Type 2 Diabetes, Impaired Renal Function · principal investigator
- N/ANCT01860599 · Effects of Aerobic Exercise in Patients With Pre-diabetesBaystate Medical Center · completed · Prediabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:51 UTC. The ranking covers the 200 most relevant of 186 PubMed records, and a shared surname and initials can bring in a namesake. All 186 on PubMed
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.N Engl J Med · 2016860 citationsRCR 31.0
- Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.Lancet · 2018813 citationsRCR 33.5
- Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.N Engl J Med · 2017799 citationsRCR 31.5
- Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study.J Am Coll Cardiol · 2012541 citationsRCR 17.2
- Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.J Clin Oncol · 2018541 citationsRCR 17.7
- Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.Hepatology · 2013416 citationsRCR 15.0
- Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.Lancet Neurol · 2017288 citationsRCR 11.7
- 285 citationsRCR 9.5
- Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system.J Am Coll Cardiol · 2008225 citationsRCR 5.5
- 216 citationsRCR 6.3